Literature DB >> 18336239

Progression and disruption of advanced atherosclerotic plaques in murine models.

Michael E Rosenfeld1, Michelle M Averill, Brian J Bennett, Stephen M Schwartz.   

Abstract

The innominate artery is a predilection site for atherosclerotic lesion formation in hyperlipidemic mice. The lesions at this site in chow-fed apo E-/- mice progress from fatty streaks through stages that include atheroma with large necrotic areas, fibro-fatty nodules containing chondrocyte-like cells and highly calcified, acellular plaques. The advanced lesions in the innominate arteries of the apo E-/- mice exhibit a reproducible frequency of intra-plaque hemorrhage that occurs primarily as a result of fissures through lateral fatty streaks that form adjacent to or on top of the established plaques. However, this plaque disruption is not equivalent to plaque rupture in human lesions where there is rupture of well formed fibrous caps. The plaque disruption in the lesions of the chow-fed apo E-/- mice also do not lead to formation of occlusive thrombi, the predominant marker of plaque rupture in humans. Thus, although the lesions in the innominate arteries of hyperlipidemic mice progress to very advanced stages of the disease, they are not, in our opinion a model in which to study the mechanisms of plaque rupture in humans. The advanced lesions in the innominate arteries of the apo E-/- mice may however be adequate models for studying vascular fibrosis and calcification.

Entities:  

Mesh:

Year:  2008        PMID: 18336239      PMCID: PMC2942086          DOI: 10.2174/138945008783755575

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  53 in total

1.  p53 and atherosclerosis.

Authors:  I Tabas
Journal:  Circ Res       Date:  2001-04-27       Impact factor: 17.367

2.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

Authors:  Frank Tacke; David Alvarez; Theodore J Kaplan; Claudia Jakubzick; Rainer Spanbroek; Jaime Llodra; Alexandre Garin; Jianhua Liu; Matthias Mack; Nico van Rooijen; Sergio A Lira; Andreas J Habenicht; Gwendalyn J Randolph
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice.

Authors:  Sandra A Schreyer; Cynthia Vick; Theodore C Lystig; Paul Mystkowski; Renée C LeBoeuf
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-01       Impact factor: 4.310

4.  Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

Authors:  S A Steitz; M Y Speer; G Curinga; H Y Yang; P Haynes; R Aebersold; T Schinke; G Karsenty; C M Giachelli
Journal:  Circ Res       Date:  2001-12-07       Impact factor: 17.367

5.  Simvastatin promotes atherosclerotic plaque stability in apoE-deficient mice independently of lipid lowering.

Authors:  Florian Bea; Erwin Blessing; Brian Bennett; Michael Levitz; Elizabeth P Wallace; Michael E Rosenfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

6.  Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice.

Authors:  Anne Braun; Bernardo L Trigatti; Mark J Post; Kaori Sato; Michael Simons; Jay M Edelberg; Robert D Rosenberg; Mark Schrenzel; Monty Krieger
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

Review 7.  Animal models of spontaneous plaque rupture: the holy grail of experimental atherosclerosis research.

Authors:  Michael E Rosenfeld; Kevin G S Carson; Jason L Johnson; Helen Williams; Christopher L Jackson; Stephen M Schwartz
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

8.  Estrogen inhibits the initiation of fatty streaks throughout the vasculature but does not inhibit intra-plaque hemorrhage and the progression of established lesions in apolipoprotein E deficient mice.

Authors:  Michael E Rosenfeld; Katalin Kauser; Baby Martin-McNulty; Patti Polinsky; Stephen M Schwartz; Gabor M Rubanyi
Journal:  Atherosclerosis       Date:  2002-10       Impact factor: 5.162

9.  High-density lipoprotein regulates calcification of vascular cells.

Authors:  Farhad Parhami; Benjamin Basseri; Jason Hwang; Yin Tintut; Linda L Demer
Journal:  Circ Res       Date:  2002-10-04       Impact factor: 17.367

10.  Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages.

Authors:  Atsushi Shioi; Miwako Katagi; Yasuhisa Okuno; Katsuhito Mori; Shuichi Jono; Hidenori Koyama; Yoshiki Nishizawa
Journal:  Circ Res       Date:  2002-07-12       Impact factor: 17.367

View more
  20 in total

Review 1.  Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council.

Authors:  Peggy Robinet; Dianna M Milewicz; Lisa A Cassis; Nicholas J Leeper; Hong S Lu; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-01-04       Impact factor: 8.311

2.  Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Andrea Callegari; Yuhua Liu; Collin C White; Alan Chait; Peter Gough; Elaine W Raines; David Cox; Terrance J Kavanagh; Michael E Rosenfeld
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

3.  Atherosclerosis lesion progression during inhalation exposure to environmental tobacco smoke: a comparison to concentrated ambient air fine particles exposure.

Authors:  Lung Chi Chen; Chunli Quan; Jing Shiang Hwang; Ximei Jin; Qiang Li; Mianhua Zhong; Sanjay Rajagopalan; Qinghua Sun
Journal:  Inhal Toxicol       Date:  2010-05       Impact factor: 2.724

Review 4.  Molecular imaging of coronary atherosclerosis and myocardial infarction: considerations for the bench and perspectives for the clinic.

Authors:  Florian Leuschner; Matthias Nahrendorf
Journal:  Circ Res       Date:  2011-03-04       Impact factor: 17.367

5.  Blocking TLR2 activity diminishes and stabilizes advanced atherosclerotic lesions in apolipoprotein E-deficient mice.

Authors:  Xiao-xing Wang; Xiao-xi Lv; Jia-ping Wang; Hui-min Yan; Zi-yan Wang; Han-zhi Liu; Xiao-ming Fu; Zhuo-wei Hu
Journal:  Acta Pharmacol Sin       Date:  2013-07-15       Impact factor: 6.150

6.  VLDL best predicts aortic root atherosclerosis in LDL receptor deficient mice.

Authors:  Paul A VanderLaan; Catherine A Reardon; Ronald A Thisted; Godfrey S Getz
Journal:  J Lipid Res       Date:  2008-10-28       Impact factor: 5.922

7.  Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis.

Authors:  Alison M Strack; Ester Carballo-Jane; Sheng-Ping Wang; Jiyan Xue; Xiaoli Ping; Lesley Ann McNamara; Anil Thankappan; Olga Price; Michael Wolff; T J Wu; Douglas Kawka; Michele Mariano; Charlotte Burton; Ching H Chang; Jing Chen; John Menke; Silvi Luell; Emanuel I Zycband; Xinchun Tong; Richard Raubertas; Carl P Sparrow; Brian Hubbard; John Woods; Gary O'Neill; M Gerard Waters; Ayesha Sitlani
Journal:  J Lipid Res       Date:  2012-10-28       Impact factor: 5.922

8.  Effects of mechanical properties and atherosclerotic artery size on biomechanical plaque disruption - mouse vs. human.

Authors:  Laurent M Riou; Alexis Broisat; Catherine Ghezzi; Gérard Finet; Gilles Rioufol; Ahmed M Gharib; Roderic I Pettigrew; Jacques Ohayon
Journal:  J Biomech       Date:  2014-01-13       Impact factor: 2.712

9.  Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering.

Authors:  Longbiao Yao; Janet Heuser-Baker; Oana Herlea-Pana; Ryuji Iida; Qilong Wang; Ming-Hui Zou; Jana Barlic-Dicen
Journal:  Stem Cells       Date:  2012-12       Impact factor: 6.277

Review 10.  Lipids versus glucose in inflammation and the pathogenesis of macrovascular disease in diabetes.

Authors:  Michelle M Averill; Karin E Bornfeldt
Journal:  Curr Diab Rep       Date:  2009-02       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.